These benefits, along with a former report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the strategy of targeting ACKR3 as a novel way to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-related disorders. Distributing this overview implies that https://paull565wpj5.wikikali.com/user